Transplant Medicine
Patients with post-transplant autoimmune hepatitis respond well to rapamycin
Published in Hepatitis Weekly, May 30th, 2005
"Rapamycin (Rapa), one of the newer immunosuppressants, has been found to control and prevent autoimmune features in animal models. This is the first report describing the successful control of post-transplant autoimmune hepatitis (AIH) with Rapa. Post-transplant AIH is diagnosed in the presence of raised transaminases, elevated immunoglobulin G, presence of autoantibodies, and histologic changes consistent with AIH on liver biopsy," scientists in the United States report.
"It may represent a recurrence of the original AIH that led to transplantation or present as a de novo...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-05-30)
More Articles from Hepatitis Weekly
- Antiviral Therapy
Chronic hepatitis C responds well to interferon alfacon-1 combination therapy - Diagnostics
Reverse micelles detect hepatitis B virus polymerase gene point mutations - Gastroenterology
Antiviral therapy for chronic hepatitis C may reveal latent Crohn disease - Hepatitis C Therapy
Early response to therapy improves prospects for chronic hepatitis C patients - Virology
Combination therapy helps patients with hepatitis B and C virus coinfection - Acute Liver Failure
HLA homozygosity confers susceptibility to non-A non-B hepatitis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
